A recent study published in the journal Nature revealed a surprising link between COVID-19 mRNA vaccines and improved cancer outcomes. Researchers found that patients with melanoma and lung cancer who received either the Pfizer or Moderna COVID-19 vaccine in conjunction with immunotherapy experienced significantly higher survival rates compared to those who did not. This effect was observed even in patients with tumors that typically do not respond well to immunotherapy. The study suggests that the mRNA vaccines act as an alarm, triggering the immune system to recognize and kill tumor cells, potentially turning “cold” tumors “hot.” A nationwide clinical trial is planned to further investigate the inclusion of COVID-19 mRNA vaccines in standard cancer treatment, with the hope of extending the benefits of immunotherapy to a wider range of patients.
Read More
Therapists across the US are reporting a surge in patient anxiety stemming from Donald Trump’s return to power, exceeding typical political anxieties. This heightened stress is fueled by Trump’s unique ability to dominate public discourse and his administration’s policies impacting reproductive rights and LGBTQ+ communities. Many patients experience “activist burnout” and fear the erosion of democratic norms and institutions under his leadership. Therapists emphasize the importance of community support, managing news consumption, and acknowledging the collective grief caused by the political climate. The pervasive nature of Trump’s influence makes it difficult for individuals to disconnect from the constant source of anxiety he generates.
Read More
As I read the heart-wrenching stories shared by individuals who have lost loved ones to glioblastoma, my heart aches with empathy and understanding. The pain, the suffering, and the devastation caused by this aggressive brain tumor are unimaginable. The toll it takes on families, the despair it brings, the helplessness felt as we watch our loved ones deteriorate before our eyes, is a burden no one should have to bear.
The news of a new mRNA cancer vaccine that triggers a fierce immune response to fight malignant brain tumors is nothing short of revolutionary. The study, which shows promising results in both murine models and canine trials, offers a glimmer of hope amidst the darkness of this devastating disease.… Continue reading
John Q. Hosedrinker